Remote patient monitoring increasingly popular, even as pandemic eases, analysis of insurance claims shows

Cardiologists are the main users of RPM devices, with blood pressure diagnoses accounting for more than half of all claims made in 2021. Diabetes, which accounts for 16% of claims, is the next most active area.

By Nick Paul Taylor • March 2, 2023

Medtronic links MiniMed 780G automated insulin delivery to sustained glucose control benefits

The data indicates patients should receive automated insulin delivery earlier, rather than starting treatment with multiple daily injections, Medtronic said.

By Nick Paul Taylor • Feb. 27, 2023

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

iRhythm beats Q4 expectations, shares rise on Zio XT account openings

Progress on addressing operational issues, along with increased Zio sales, drove revenue growth, analysts said.

By Susan Kelly • Feb. 24, 2023

Insulet exceeds sales forecast amid signs Omnipod 5 is winning share in diabetes pump market

The pump will be a “share taker for some time to come,” as patients switch from rival devices, said Insulet’s CFO.

By Nick Paul Taylor • Feb. 24, 2023

Friday Q&A: GE HealthCare’s Yoder on using AI to drive precision care

The healthcare technology and diagnostics firm, now a standalone company, will integrate the acquisition of AI software developer Caption Health under Yoder’s lead.

By Susan Kelly • Feb. 23, 2023

General Catalyst’s Elena Viboch shares medtech predictions for 2023

The venture-capital firm partner talked about the future of AI in radiology and pathology as well as the use of technology in clinical trials.

By Elise Reuter • Feb. 22, 2023

Biden upholds finding that Apple Watch violated AliveCor’s patents

A ban on the infringing Apple Watches could be enacted under a ruling by the International Trade Commission, but a separate patent case must be resolved first.

By Elise Reuter • Feb. 21, 2023

AI devices need dedicated FDA regulatory pathway to reduce bias risk, say researchers

Scientists argue for a new regulatory process to prevent AI software from reinforcing existing health disparities.

By Nick Paul Taylor • Feb. 16, 2023

Insulet pays Bigfoot Biomedical $25M for pump-based automated insulin delivery technology

Insulet framed the Bigfoot deal as a way to double its IP portfolio and strengthen its position in the insulin pump market.

By Nick Paul Taylor • Feb. 14, 2023

How the right infrastructure increases the resilience of your HealthTech devices

Ensure your HealthTech devices are always available, always secure and always up-to-date.

Feb. 13, 2023

GE HealthCare agrees to buy AI imaging firm Caption Health in second acquisition

GE HealthCare plans to pair its ultrasound machines with Caption’s applications for early disease detection.

By Elise Reuter • Feb. 10, 2023

Bayer partners with Huma to create online tool for assessing cardiovascular risk factors

The algorithm uses a large-scale biomedical database to predict whether a person is at higher, average or lower risk of developing heart disease over the next 10 years.

By Nick Paul Taylor • Feb. 7, 2023

Sensor-loaded, $1 smart glove being tested to reduce stillbirths, maternal deaths

The researchers plan to run clinical trials to show if the device can provide an early warning system for physical impediments to birth.

By Nick Paul Taylor • Feb. 6, 2023

FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

Regulators said they are putting the industry on watch with the enforcement against GoodRx, which allegedly collected data, including patient medications, and shared it without user consent.

By Rebecca Pifer • Updated Feb. 1, 2023

CFO survey hints at funding shift from robots to wearables

The poll from accounting firm BDO found the cost and regulatory hurdles of developing robotics devices are often too high, and lower-cost, less-regulated wearables offer better returns.

By Susan Kelly • Feb. 1, 2023

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.

By Peter Green • Jan. 31, 2023

Medtronic wearable partner files for bankruptcy but plans to continue ‘without interruption’

Rockley Photonics works with two of the top five medtech companies, plus six leading smart watch makers including Apple, but has run into financial problems.

By Nick Paul Taylor • Jan. 27, 2023

Why medical device designers need to become more agile — and how they can do it

To stay competitive, medtech firms must center manufacturing in business optimization plans, while embracing a design-to-value approach, says Jennifer Samproni, Flex’s chief technology officer for its Health Solutions division.

By Jennifer Samproni • Jan. 26, 2023

Stanford team reports progress with Theranos-like finger prick blood test

The researchers have created a system for capturing and analyzing thousands of molecules from a single drop of blood.

By Nick Paul Taylor • Jan. 23, 2023

Realizing the promise of AI for medical imaging and diagnosis

Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud, explains how medtech companies can benefit from applying AI to the explosion of medical imaging data.

By Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud • Jan. 19, 2023

Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy

Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.

By Elise Reuter • Updated Jan. 18, 2023

Akili cuts 30% of staff to focus cash on growing prescription video game sales

The move comes as the company seeks a path forward after sales of $82,000 in the third quarter. Over the last five months, its share price has fallen 90%.

By Nick Paul Taylor • Jan. 13, 2023

Google sibling Verily to lay off about 200 workers as it focuses on precision risk business

The company, which has more than 1,600 employees, will stop work on some products including its healthcare analytics software program.

By Nick Paul Taylor • Jan. 12, 2023

Apple Watch infringed on Masimo patent, judge rules, raising prospect of import ban

Masimo’s CEO said the ruling “exposes Apple as a company that takes other companies’ innovations and repackages them.”

By Nick Paul Taylor • Updated Jan. 12, 2023

Beta Bionics hires Harvard diabetes expert as CMO ahead of artificial pancreas launch

Steven Russell has joined the company as chief medical officer, completing a new leadership team that began taking shape with the appointment of Sean Saint as CEO last year.

By Nick Paul Taylor • Jan. 10, 2023